Certified by Founder
Lodge
Caristo Diagnostics
start up
United Kingdom
- Oxford
- 18/04/2023
- Series A
- $16,300,000
Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions.
Our Website: https://www.caristo.com
Follow us on Twitter: https://twitter.com/CaristoHeart
- Industry Medical Equipment Manufacturing
- Website https://www.caristo.com/
- LinkedIn https://www.linkedin.com/company/caristo/people/
Related People
Frank ChengFounder
United States -
ND
Currently leading healthcare AI business. Previously led innovative businesses in robotic surgery, digital diagnostics, HCIT, and diagnostic imaging.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)